Clinical Characteristics of Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in North Indian Population of HIV/AIDS Patients Receiving HAART

Table 5

Comparison characteristics between patients with and without TB-IRIS in 123 patients with HIV-TB.

	No. TB-IRIS	TB-IRIS
	(𝑛=118)	(𝑛=5)
Age (yrs)	37 ± 10	31 ± 7
Sex (% male)	80	80
BMI (kg/m^2)	19 ± 5	18 ± 3
ATT-ART (days)	32 (21–70)	20 (18–27)
CD4 (cells/𝜇l)	136 (70–225.75)	167 (118–193)
Increase in CD4	89 (32.25–144.75)	229 (61–283)
(cells/𝜇l)
Increase in CD4 (%)	57.6 (24–181)	119 (63.5–207)
VL (log10 copies/ml)	5.21 (4.76–5.65)	5.49 (5.18–5.63)
Decrease in VL	5.19 (4.76–5.63)	5.49 (5.18–5.63)
(log10 copies/ml)
Decrease in VL (%)	99.58 (98.85–99.9)*	99.93 (99.91–99.97)*

BMI: body mass index; ATT: antituberculosis treatment; ART: antiretroviral treatment; VL: viral load
Age and BMI are presented as mean ± SD; gender as % of male; EPTB as % of TB; DTB as % of EPTB and ATT-ART gap, CD4 cell counts and viral load as median and IQR
* 𝑃=.016.